Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?

Keyphrases

• Acute Myeloid Leukemia 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Stem Cell Transplantation 100%
• First Remission 100%
• Relapse Risk 80%
• Treatment-related Mortality 60%
• High Risk 40%
• Consolidation Therapy 40%
• Allogeneic 40%
• Chemotherapy Alone 40%
• High Dose 20%
• Low Risk 20%
• Chemotherapy 20%
• Newly Diagnosed Patients 20%
• Risk Stratification 20%
• Prognostic Factors 20%
• Consolidation Chemotherapy 20%
• Intermediate Risk 20%
• Prognosticator 20%
• First Complete Remission 20%
• Unrelated Donor 20%
• Intermediate-risk Group 20%
• Low Quality Data 20%
• Limited Datasets 20%
• Haploidentical 20%
• Unfavorable Risk 20%
• Repeated Cycles 20%
• Cord Blood Transplantation 20%
• Cytogenetic Status 20%
• Group Strategy 20%
• High-dose Cytosine Arabinoside 20%

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Stem Cell Therapy 100%
• Autologous Stem Cell Transplantation 60%
• Drug Megadose 40%
• High Risk Population 40%
• Allogeneic Stem Cell Transplantation 40%
• Transplantation 20%
• Cytarabine 20%
• Decision Making 20%
• Risk Stratification 20%
• Consolidation Chemotherapy 20%
• Prognostic Factor 20%
• Cord Blood 20%
• Intermediate Risk Population 20%